Safie's 1Q results disappointed on weak one-off revenues and surging R&D cost but the specific distributor problems are easing and we would be targeting the stock as a strong buy on capitulation.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.